ALKERMES reported 1.01B in Current Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 673.98M 43.63M
Acorda Therapeutics ACOR:US $ 189.72M 31.62M
Amgen AMGN:US $ 21299M 155M
Biogen BIIB:US $ 6719.5M 167.6M
Biomarin Pharmaceutical BMRN:US $ 2288.77M 53.45M
Bluebird Bio BLUE:US $ 1097.54M 118M
Bristol Myers Squibb BMY:US $ 27111M 3081M
Coherus Biosciences CHRS:US $ 617.26M 150.22M
Eli Lilly And LLY:US $ 16604.5M 857.6M
Gilead Sciences GILD:US $ 13166M 2830M
Gw Pharmaceuticals GWPH:US $ 718.73M 10.8M
H. Lundbeck A/S LUN:DC 10.1B 240M
Heron Therapeutics HRTX:US $ 272.29M 41.91M
Horizon Pharma HZNP:US $ 1831.37M 1239.04M
Intra Cellular Therapies ITCI:US $ 690.9M 53.96M
JAZZ PHA JAZZ:US $ 3166.9M 327.33M
Johnson & Johnson JNJ:US $ 52533M 1296M
Marinus Pharmaceuticals MRNS:US $ 146.27M 51.1M
Minerva Neurosciences NERV:US $ 81.69M 54.25M
Nektar Therapeutics NKTR:US $ 1099.05M 38.95M
Neurocrine Biosciences NBIX:US $ 1085.4M 69.2M
Otsuka Holdings 4578:JP Y 1014750M 11023M
Regeneron Pharmaceuticals REGN:US $ 10055.1M 276M
Revance Therapeutics RVNC:US $ 450M 102K
Teva Pharmaceutical Industries TEVA:US $ 12401M 604M
Vertex Pharmaceuticals VRTX:US $ 8200.38M 67M
Zogenix ZGNX:US $ 454.73M 67.44M